We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

ITC To Investigate Sanofi Over Insulin Delivery Patent

Law360 (June 8, 2006, 12:00 AM EDT) -- The International Trade Commission plans to investigate whether drug maker Sanofi-Aventis violated patent laws in what has turned into a bittersweet struggle over an insulin delivery system patent between the French company and Danish drug maker Novo Nordisk A/S.

The ITC said Wednesday it will hold an initial hearing to rule on whether Sanofi breached patent regulations, a decision that could block the company from importing its handheld OptiClik pen system for Type 1 and Type 2 diabetes into the United States.

Novo Nordisk launched a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.